MAPT and Alzheimer disease: Endophenoptypes were assessed to characterise early AD-like events based on predominantely intracellular APP/βA and tau expression, with methods relevant for translational medicine including immunohistochemistry, electrophysiology, cognition, actimetry, electro-encephalography (EEG) and metabolic imaging using microPET.